Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Mometasone - Merck & Co

Next Previous
X
Search
Drug Profile

Mometasone - Merck & Co

Alternative Names: Altosone; Asmanex Twisthaler; Ecotone; Ecural; Elica; Elocon; Fulmeta; Mometasone furoate monohydrate; Nasonex; Novasone; Rinelon; Rivelon; SCH 32088; Uniclar

Latest Information Update: 05 Nov 2023

Price :

$50 *

Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Schering-Plough
  • Developer Merck & Co
  • Class Anti-inflammatories; Antiallergics; Antiasthmatics; Chlorinated hydrocarbons; Furans; Glucocorticoids; Phenanthrenes; Pregnadienediols; Skin disorder therapies; Small molecules
  • Mechanism of Action Glucocorticoid receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Allergic rhinitis; Asthma; Nasal polyps; Perennial allergic rhinitis; Seasonal allergic rhinitis; Sinusitis; Skin disorders
  • No development reported Chronic obstructive pulmonary disease

Most Recent Events

  • 10 May 2018 Kyorin Pharmaceutical acquires distribution rights from MSD for mometasone for Allergic rhinitis in Japan
  • 28 Feb 2017 Merck has patent protection for mometasone (Asmanex®) in Europe and Japan (Merck Annual report 2016)
  • 15 Sep 2016 MSD and Kyorin agree to co-promote Nasonex® in Allergic rhinitis in Japan

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top